Related Experiment Video

Updated: Jul 8, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

The genetics of Adamantiades-Behcet's disease

K Durrani1, G N Papaliodis

  • 1Harvard Medical School, Boston, MA 02114, USA.

Seminars in Ophthalmology
|January 25, 2008
PubMed

Insights

Adamanitiades-Behcet's disease (ABD) is a relapsing vasculitis with a genetic component, likely involving HLA-B51. Environmental triggers may activate the immune system in susceptible individuals, leading to systemic symptoms.

Area of Science:

  • Immunology
  • Genetics
  • Rheumatology

Background:

  • Adamanitiades-Behcet's disease (ABD) is a systemic vasculitis characterized by relapsing inflammatory episodes.
  • The condition can affect multiple organ systems, including the eyes and skin, potentially leading to blindness.

Purpose of the Study:

  • To explore the genetic basis of Adamanitiades-Behcet's disease.
  • To identify potential environmental triggers for the disease.

Main Methods:

  • Review of current research on ABD pathogenesis.
  • Analysis of genetic associations, focusing on MHC genes like HLA-B51.

Main Results:

  • Current research suggests a significant genetic predisposition to ABD.
  • Specific MHC genes, particularly HLA-B51, are strongly implicated as susceptibility factors.

Conclusions:

  • Genetic factors play a crucial role in the development of Adamanitiades-Behcet's disease.
  • Environmental factors likely interact with genetic susceptibility to trigger disease manifestations.
  • Identifying responsible genes could lead to improved diagnostics and treatments for this condition.

More Related Videos

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane07:38

Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane

Published on: March 30, 2015

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...